• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-甲基-D-天冬氨酸受体:分布、作用及对神经精神疾病的见解

NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders.

作者信息

Beaurain Marie, Salabert Anne-Sophie, Payoux Pierre, Gras Emmanuel, Talmont Franck

机构信息

ToNIC, Toulouse NeuroImaging Center, INSERM, UPS, Université de Toulouse, 31024 Toulouse, France.

Laboratoire Hétérochimie Fondamentale et Appliquée (LHFA, UMR 5069), CNRS, UPS, Université de Toulouse, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.

出版信息

Pharmaceuticals (Basel). 2024 Sep 25;17(10):1265. doi: 10.3390/ph17101265.

DOI:10.3390/ph17101265
PMID:39458906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11509972/
Abstract

BACKGROUND

N-methyl-D-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family. These ligand-gated channels are entwined with numerous fundamental neurological functions within the central nervous system (CNS), and numerous neuropsychiatric disorders may arise from their malfunction.

METHODS

The purpose of the present review is to provide a detailed description of NMDARs by addressing their molecular structures, activation mechanisms, and physiological roles in the mammalian brain. In the second part, their role in various neuropsychiatric disorders including stroke, epilepsy, anti-NMDA encephalitis, Alzheimer's and Huntington's diseases, schizophrenia, depression, neuropathic pain, opioid-induced tolerance, and hyperalgesia will be covered.

RESULTS

Finally, through a careful exploration of the main non-competitive NMDARs antagonists (channel-blockers).

CONCLUSION

We discuss the strengths and limitations of the various molecular structures developed for diagnostic or therapeutic purposes.

摘要

背景

N-甲基-D-天冬氨酸受体(NMDARs)是离子型谷氨酸受体家族的成员。这些配体门控通道与中枢神经系统(CNS)内众多基本神经功能密切相关,其功能异常可能引发多种神经精神疾病。

方法

本综述旨在通过阐述NMDARs的分子结构、激活机制及其在哺乳动物大脑中的生理作用,对其进行详细描述。第二部分将涵盖它们在各种神经精神疾病中的作用,包括中风、癫痫、抗NMDAR脑炎、阿尔茨海默病和亨廷顿病、精神分裂症、抑郁症、神经性疼痛、阿片类药物诱导的耐受性和痛觉过敏。

结果

最后,通过对主要非竞争性NMDARs拮抗剂(通道阻滞剂)的仔细探究。

结论

我们讨论了为诊断或治疗目的而开发的各种分子结构的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/905021bd78c5/pharmaceuticals-17-01265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/8b7e9f3eef30/pharmaceuticals-17-01265-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/961fc1cf800d/pharmaceuticals-17-01265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/905021bd78c5/pharmaceuticals-17-01265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/8b7e9f3eef30/pharmaceuticals-17-01265-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/961fc1cf800d/pharmaceuticals-17-01265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11b/11509972/905021bd78c5/pharmaceuticals-17-01265-g003.jpg

相似文献

1
NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders.N-甲基-D-天冬氨酸受体:分布、作用及对神经精神疾病的见解
Pharmaceuticals (Basel). 2024 Sep 25;17(10):1265. doi: 10.3390/ph17101265.
2
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.神经疾病中的谷氨酸受体抗体:抗AMPA - GluR3抗体、抗NMDA - NR1抗体、抗NMDA - NR2A/B抗体、抗mGluR1抗体或抗mGluR5抗体存在于以下疾病患者的亚组中:癫痫、脑炎、小脑共济失调、系统性红斑狼疮(SLE)和神经精神性SLE、干燥综合征、精神分裂症、躁狂症或中风。这些自身免疫性抗谷氨酸受体抗体可在少数脑区与神经元结合,激活谷氨酸受体,降低谷氨酸受体的表达,损害谷氨酸诱导的信号传导和功能,激活血脑屏障内皮细胞,杀死神经元,损伤大脑,在动物模型中诱发行为/精神/认知异常和共济失调,并且在一些患者中可通过免疫疗法去除或使其失活。
J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1.
3
Activation Mechanisms of the NMDA ReceptorN-甲基-D-天冬氨酸受体的激活机制
4
NMDARs in neurological diseases: a potential therapeutic target.神经疾病中的N-甲基-D-天冬氨酸受体:一个潜在的治疗靶点。
Int J Neurosci. 2015 May;125(5):315-27. doi: 10.3109/00207454.2014.940941. Epub 2014 Jul 30.
5
The chemical biology of clinically tolerated NMDA receptor antagonists.临床耐受性NMDA受体拮抗剂的化学生物学
J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x.
6
Glutamate in CNS disorders as a target for drug development: an update.中枢神经系统疾病中的谷氨酸作为药物开发靶点:最新进展
Drug News Perspect. 1998 Nov;11(9):523-69. doi: 10.1358/dnp.1998.11.9.863689.
7
NMDA Receptors in the Central Nervous System.中枢神经系统中的N-甲基-D-天冬氨酸受体
Methods Mol Biol. 2017;1677:1-80. doi: 10.1007/978-1-4939-7321-7_1.
8
Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.正变构调节作为抗 NMDA 受体脑炎的一种潜在治疗策略。
J Neurosci. 2018 Mar 28;38(13):3218-3229. doi: 10.1523/JNEUROSCI.3377-17.2018. Epub 2018 Feb 23.
9
Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor.作用于 NMDA 受体的变构正调节剂的作用机制。
Mol Pharmacol. 2024 Nov 18;106(6):334-353. doi: 10.1124/molpharm.124.001019.
10
Role of Grina/Nmdara1 in the Central Nervous System Diseases.Grina/Nmdara1 在中枢神经系统疾病中的作用。
Curr Neuropharmacol. 2020;18(9):861-867. doi: 10.2174/1570159X18666200303104235.

引用本文的文献

1
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.神经退行性疾病和免疫性疾病患者脑脊液中N-甲基-D-天冬氨酸受体亚基的改变
J Neurochem. 2025 Aug;169(8):e70192. doi: 10.1111/jnc.70192.
2
The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia.炎症关联:揭示阿尔茨海默病和精神分裂症的共同途径及有前景的治疗方法
Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.
3
Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA.

本文引用的文献

1
Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease.氟乙基去甲文拉法辛(FENM)在阿尔茨海默病小鼠模型中与 sigma-1 受体激动剂联合使用显示出协同保护作用。
Neuropharmacology. 2024 Jan 1;242:109733. doi: 10.1016/j.neuropharm.2023.109733. Epub 2023 Oct 14.
2
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.N-甲基-D-天冬氨酸受体调节剂在精神病学中的治疗潜力。
Neuropsychopharmacology. 2024 Jan;49(1):51-66. doi: 10.1038/s41386-023-01614-3. Epub 2023 Jun 27.
3
Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signaling.
顺铂通过神经炎症、氧化应激和谷氨酸能受体mRNA的过表达诱导大鼠海马神经毒性和认知障碍。
Front Pharmacol. 2025 May 30;16:1592511. doi: 10.3389/fphar.2025.1592511. eCollection 2025.
4
Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase.多个位点及其他位点使tau蛋白成为Fyn激酶SH3结构域的一个适应性粘性表面。
Angew Chem Int Ed Engl. 2025 Jul 7;64(28):e202504292. doi: 10.1002/anie.202504292. Epub 2025 May 23.
5
Structure-Activity Relationship of NMDA Receptor Ligands and Their Activities on the ERK Activation through Metabotropic Signaling Pathway.NMDA受体配体的构效关系及其通过代谢型信号通路对ERK激活的作用
Biomol Ther (Seoul). 2025 Mar 1;33(2):278-285. doi: 10.4062/biomolther.2024.216. Epub 2025 Feb 12.
脑信号中的兴奋性 GluN1/GluN3A 甘氨酸受体(eGlyRs)。
Trends Neurosci. 2023 Aug;46(8):667-681. doi: 10.1016/j.tins.2023.05.002. Epub 2023 May 28.
4
Pharmacological Characterization of [F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model.[F]-FNM 的药理学特征及 NMDA 受体激活在大鼠脑损伤模型中的评价。
Mol Imaging Biol. 2023 Aug;25(4):692-703. doi: 10.1007/s11307-023-01811-y. Epub 2023 Mar 21.
5
Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.N-甲基-D-天冬氨酸受体(NMDARs)在癫痫中的作用。
Front Mol Neurosci. 2022 Jan 7;14:797253. doi: 10.3389/fnmol.2021.797253. eCollection 2021.
6
Antibody-mediated autoimmune encephalitis: A practical approach.抗体介导的自身免疫性脑炎:一种实用方法。
Cleve Clin J Med. 2021 Aug 2;88(8):459-471. doi: 10.3949/ccjm.88a.20122.
7
Structural basis of ketamine action on human NMDA receptors.氯胺酮作用于人类 NMDA 受体的结构基础。
Nature. 2021 Aug;596(7871):301-305. doi: 10.1038/s41586-021-03769-9. Epub 2021 Jul 28.
8
Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior.氟乙基去甲文拉法辛,一种新型 NMDA 受体拮抗剂,用于预防和治疗应激相关的适应不良行为。
Biol Psychiatry. 2021 Oct 1;90(7):458-472. doi: 10.1016/j.biopsych.2021.04.024. Epub 2021 May 9.
9
Fluoroethylnormemantine, A Novel Derivative of Memantine, Facilitates Extinction Learning Without Sensorimotor Deficits.氟乙基去甲金刚烷胺,一种美金刚的新型衍生物,可促进无感觉运动缺陷的消退学习。
Int J Neuropsychopharmacol. 2021 Jul 14;24(6):519-531. doi: 10.1093/ijnp/pyab007.
10
Superoxide and Non-ionotropic Signaling in Neuronal Excitotoxicity.神经元兴奋毒性中的超氧化物与非离子型信号传导
Front Neurosci. 2020 Sep 3;4:861. doi: 10.3389/fnins.2020.00861. eCollection 2020.